Sensitivity analysis: results of the multivariable logistic regression analyses of psychiatric sequelae after COVID-19 infection
Acute: 1–3 months after COVID-19 infection | Delayed: 4–6 months after COVID-19 infection | |||||||
COVID-19 vs influenza | COVID-19 vs other RTI | COVID-19 vs influenza | COVID-19 vs other RTI | |||||
OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |
Mood/anxiety/psychotic disorder | 1.38 (1.02 to 1.87) | 0.038 | 0.77 (0.60 to 0.99) | 0.045 | 1.09 (0.70 to 1.70) | 0.688 | 0.62 (0.42 to 0.91) | 0.097 |
Mood disorder | 1.55 (1.05 to 2.29) | 0.026 | 0.97 (0.71 to 1.32) | 0.823 | 0.76 (0.42 to 1.38) | 0.372 | 0.50 (0.29 to 0.85) | 0.190 |
Anxiety disorder | 1.04 (0.62 to 1.74) | 0.885 | 0.51 (0.35 to 0.76) | 0.001 | 1.15 (0.54 to 2.43) | 0.715 | 0.56 (0.30 to 1.03) | 0.011 |
Psychotic disorder | 1.79 (1.19 to 2.70) | 0.005 | 0.77 (0.56 to 1.05) | 0.097 | 1.27 (0.69 to 2.35) | 0.436 | 0.56 (0.34 to 0.94) | 0.027 |
Insomnia | 2.88 (2.18 to 3.81) | <0.001 | 1.80 (1.42 to 2.27) | <0.001 | 1.22 (0.82 to 1.80) | 0.322 | 0.69 (0.49 to 0.98) | 0.036 |
In this sensitivity analysis, psychiatric sequelae were defined using both recorded diagnoses and drug prescriptions.
COVID-19, coronavirus disease 2019; RTI, respiratory tract infection.